Loading clinical trials...
Loading clinical trials...
Prospective, Multi-Center, Non-Randomized Study to Evaluate the 3EO Health SARS-CoV-2 Molecular Diagnostic Test
Conditions
Interventions
In Vitro
Locations
5
United States
Sarkis Clinical Trials
Gainesville, Florida, United States
I.V.A.M. Clinical & Investigational Center
Miami, Florida, United States
Sunrise Research Institute
Sunrise, Florida, United States
Vytalus Medical Atascocita
Humble, Texas, United States
Vytalus Medical
Kingwood, Texas, United States
Start Date
October 7, 2022
Primary Completion Date
November 18, 2022
Completion Date
November 18, 2022
Last Updated
December 2, 2022
NCT06927622
NCT05825651
NCT06036134
NCT05234372
NCT05894655
NCT07199972
Lead Sponsor
3EO Health
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions